| RS2549182925 |
KAT6B
|
Health Risk |
Pathogenic |
KAT6B-related disorder, KAT6B-related disorder |
| RS2549184163 |
KAT6B
|
Health Risk |
Likely pathogenic |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS2549184173 |
KAT6B
|
Health Risk |
Likely pathogenic |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS2549189964 |
SMARCC1
|
Health Risk |
Likely pathogenic |
Hydrocephalus, congenital |
| RS2549193603 |
LINS1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal recessive 27 |
| RS2549196742 |
KAT6B
|
Health Risk |
Likely pathogenic |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS2549197648 |
KAT6B
|
Health Risk |
Pathogenic |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS2549197942 |
KAT6B
|
Health Risk |
Pathogenic |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS2549198858 |
KAT6B
|
Health Risk |
Pathogenic/Likely pathogenic |
Genitopatellar syndrome, Blepharophimosis - intellectual disability syndrome |
| RS2549199460 |
KAT6B
|
Health Risk |
Pathogenic |
KAT6B-related disorder, KAT6B-related disorder |
| RS2549200429 |
MECOM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2549202399 |
KAT6B
|
Health Risk |
Pathogenic |
KAT6B-related disorder, KAT6B-related disorder |
| RS2549203895 |
KAT6B
|
Health Risk |
Pathogenic |
Genitopatellar syndrome, Blepharophimosis - intellectual disability syndrome |
| RS2549207711 |
KAT6B
|
Health Risk |
Likely pathogenic |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS2549208798 |
KAT6B
|
Health Risk |
Pathogenic |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS2549212884 |
USP7
|
Health Risk |
Pathogenic |
Hao-Fountain syndrome due to USP7 mutation, Gastric cancer |
| RS2549213434 |
KAT6B
|
Health Risk |
Pathogenic |
Blepharophimosis - intellectual disability syndrome, SBBYS type |
| RS2549214778 |
KAT6B
|
Health Risk |
Pathogenic |
Blepharophimosis - intellectual disability syndrome, SBBYS type |
| RS2549220874 |
USP7
|
Health Risk |
Likely pathogenic |
Hao-Fountain syndrome due to USP7 mutation, Hao-Fountain syndrome due to USP7 mutation |
| RS2549222611 |
USP7
|
Health Risk |
Likely pathogenic |
Hao-Fountain syndrome, Hao-Fountain syndrome |
| RS2549223409 |
USP7
|
Health Risk |
Likely pathogenic |
Hao-Fountain syndrome, Hao-Fountain syndrome |
| RS2549225175 |
USP7
|
Health Risk |
Likely pathogenic |
Hao-Fountain syndrome, Hao-Fountain syndrome |
| RS2549226325 |
USP7
|
Health Risk |
Pathogenic |
— |
| RS2549226398 |
USP7
|
Health Risk |
Pathogenic |
— |
| RS2549226442 |
USP7;USP7-AS1
|
Health Risk |
Pathogenic |
Hao-Fountain syndrome, Hao-Fountain syndrome |
| RS2549229217 |
USP7
|
Health Risk |
Pathogenic |
Hao-Fountain syndrome due to USP7 mutation, Hao-Fountain syndrome due to USP7 mutation |
| RS2549230941 |
USP7
|
Health Risk |
Likely pathogenic |
Hao-Fountain syndrome, Hao-Fountain syndrome |
| RS2549232757 |
USP7
|
Health Risk |
Likely pathogenic |
Hao-Fountain syndrome, Hao-Fountain syndrome |
| RS2549240624 |
USP7
|
Health Risk |
Likely pathogenic |
Hao-Fountain syndrome, Hao-Fountain syndrome |
| RS2549240827 |
USP7
|
Health Risk |
Likely pathogenic |
— |
| RS2549241840 |
USP7
|
Health Risk |
Likely pathogenic |
Hao-Fountain syndrome, Hao-Fountain syndrome |
| RS2549242502 |
USP7
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2549242516 |
USP7
|
Health Risk |
Likely pathogenic |
Hao-Fountain syndrome, Hao-Fountain syndrome |
| RS2549242612 |
USP7
|
Health Risk |
Likely pathogenic |
Hao-Fountain syndrome, USP7-related disorder |
| RS2549243181 |
DHX30
|
Health Risk |
Likely pathogenic |
— |
| RS2549244890 |
USP7
|
Health Risk |
Likely pathogenic |
Hao-Fountain syndrome, Hao-Fountain syndrome |
| RS2549244919 |
USP7
|
Health Risk |
Pathogenic |
Hao-Fountain syndrome, Hao-Fountain syndrome |
| RS2549246727 |
USP7
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Neoplasm |
| RS2549250330 |
USP7
|
Health Risk |
Pathogenic |
Hao-Fountain syndrome, Hao-Fountain syndrome |
| RS2549255659 |
SYNE2
|
Health Risk |
Likely pathogenic |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS2549268527 |
NBEA
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Neurodevelopmental disorder with or without early-onset generalized epilepsy |
| RS2549268925 |
MECOM
|
Health Risk |
Pathogenic |
MECOM-associated syndrome, MECOM-associated syndrome |
| RS2549269042 |
MECOM
|
Health Risk |
Likely pathogenic |
— |
| RS2549269204 |
MECOM
|
Health Risk |
Likely pathogenic |
Radioulnar synostosis with amegakaryocytic thrombocytopenia 2, Radioulnar synostosis with amegakaryocytic thrombocytopenia 2 |
| RS2549284450 |
GPHN
|
Health Risk |
Likely pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C |
| RS2549285187 |
DOCK3
|
Health Risk |
Likely pathogenic |
DOCK3-related disorder, DOCK3-related disorder |
| RS2549295022 |
DHX30
|
Health Risk |
Pathogenic |
Autism, susceptiblity to |
| RS2549297131 |
DHX30
|
Health Risk |
Likely pathogenic |
— |
| RS2549301563 |
DHX30
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2549306131 |
WARS1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with microcephaly and speech delay, with or without brain abnormalities |
| RS2549307285 |
DHX30
|
Health Risk |
Likely pathogenic |
— |
| RS2549312956 |
THUMPD1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with speech delay and variable ocular anomalies, Neurodevelopmental disorder with speech delay and variable ocular anomalies |
| RS2549321348 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2549378092 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2549384286 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2549416400 |
SYNE2
|
Health Risk |
Likely pathogenic |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS2549467189 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS2549468222 |
SPTBN1
|
Health Risk |
Likely pathogenic |
Developmental delay, impaired speech |
| RS2549494030 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2549499057 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2549499286 |
GPHN
|
Health Risk |
Likely pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C |
| RS2549502583 |
SPTBN1
|
Health Risk |
Likely pathogenic |
Developmental delay, impaired speech |
| RS2549506201 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2549506563 |
SPTBN1
|
Health Risk |
Likely pathogenic |
— |
| RS2549511876 |
SPTBN1
|
Health Risk |
Pathogenic |
Developmental delay, impaired speech |
| RS2549520186 |
SPTBN1
|
Health Risk |
Likely pathogenic |
Developmental delay, impaired speech |
| RS2549520266 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2549524360 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2549525393 |
SPTBN1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2549525926 |
SPTBN1
|
Health Risk |
Likely pathogenic |
— |
| RS2549530685 |
SPTBN1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2549543024 |
SPTBN1
|
Health Risk |
Likely pathogenic |
Developmental delay, impaired speech |
| RS2549545213 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2549545421 |
PCDH15
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2549545616 |
PCDH15
|
Health Risk |
Likely pathogenic |
PCDH15-related disorder, PCDH15-related disorder |
| RS2549545673 |
PCDH15
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2549545770 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2549551292 |
SPTBN1
|
Health Risk |
Likely pathogenic |
Developmental delay, impaired speech |
| RS2549554387 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2549554737 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2549555343 |
SPTBN1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2549555672 |
SPTBN1
|
Health Risk |
Likely pathogenic |
— |
| RS2549560021 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2549562759 |
SPTBN1
|
Health Risk |
Pathogenic |
Developmental delay, impaired speech |
| RS2549570027 |
SPTBN1
|
Health Risk |
Pathogenic |
Developmental delay, impaired speech |
| RS2549575000 |
SPTBN1
|
Health Risk |
Likely pathogenic |
Developmental delay, impaired speech |
| RS2549575262 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS2549594379 |
MAB21L1
|
Health Risk |
Pathogenic |
— |
| RS2549597698 |
GPHN
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C |
| RS2549615253 |
GPHN
|
Health Risk |
Likely pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C |
| RS2549615369 |
GPHN
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C |
| RS2549615601 |
GPHN
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C |
| RS2549619648 |
GPHN
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C |
| RS2549619766 |
GPHN
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C |
| RS2549629250 |
ST3GAL3
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, Early-infantile DEE |
| RS2549631880 |
RALGAPA1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia, neonatal respiratory insufficiency |
| RS2549714620 |
NBEA
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without early-onset generalized epilepsy, Neurodevelopmental disorder with or without early-onset generalized epilepsy |
| RS2549719217 |
ATP6V1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 93, Autosomal recessive cutis laxa type 2D |
| RS2549720448 |
ATP6V1A
|
Health Risk |
Likely pathogenic |
— |
| RS2549722082 |
ATP6V1A
|
Health Risk |
Pathogenic |
— |